United Kingdom Infertility Treatment Devices and Equipment Market Insight
The United Kingdom Infertility Treatment Devices and Equipment Market is growing at an 10.95%CAGR, driven by infertility, delayed parenthood, IVF growth, NHS ART support, and advanced embryo technologies improving outcomes.
United Kingdom Infertility Treatment Devices and Equipment Market Insights Forecasts to 2035
- The United KingdomInfertility Treatment Devices and Equipment Market Size Was Estimated at USD 13.8Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 10.95% from 2025 to 2035
- The United KingdomInfertility Treatment Devices and Equipment Market Size is Expected to Reach USD 39.01Million by 2035
Notable Insights for United Kingdom Infertility Treatment Devices and Equipment Market
- By device type, IVF laboratory equipment dominates, accounting for approximately 45–50% share due to high usage in embryo culture and fertilisation procedures
- Embryo incubators and micromanipulation systems together contribute nearly 30–35% of total market demand
- Around 1 in 6 couples in the UK experience infertility, driving consistent demand for assisted reproductive technologies
- Approximately 65–70% of IVF cycles in the UK rely on advanced embryo selection and imaging systems for improved success rates
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Infertility Treatment Devices and Equipment Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Infertility Treatment Devices and Equipment Market
- Vitrolife
- CooperSurgical
- Merck KGaA (EMD Serono Fertility)
- Cook Medical
- FUJIFILM Irvine Scientific
- Hamilton Thorne
- Esco Medical
- Thermo Fisher Scientific
- Others
Recent Developments:
- In June 2024, Barinthus Biotherapeutics reported Phase 2 data for VTP-300 showing reduced HBsAg levels and potential nucleos(t)ide analogue discontinuation in selected chronic hepatitis B patients supporting therapeutic vaccine development.
- In March 2024, Gilead expanded Vemlidy (tenofovir alafenamide) indication for pediatric chronic hepatitis B patients, reinforcing antiviral treatment continuity and supporting long-term hepatitis B management strategies across global markets globally.
Market Segmentation:
United Kingdom Infertility Treatment Devices and Equipment Market, By Device Type
- IVF Laboratory Equipment
- Embryo Incubators
- Micromanipulation Systems
- Cryopreservation Equipment
- Imaging & Monitoring Systems
- Others
United Kingdom Infertility Treatment Devices and Equipment Market, By Procedure Type
- In Vitro Fertilization (IVF)
- Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination
- Others
United Kingdom Infertility Treatment Devices and Equipment Market, By End User
- Fertility Clinics
- Hospitals
- Research Institutes
- Specialty Centers
United Kingdom Infertility Treatment Devices and Equipment Market, By Distribution Channel
- Direct Sales
- Hospital Procurement
- Specialty Distributors
- Online Channels
Expert Views:
The UK infertility treatment devices and equipment market is expected to expand steadily due to increasing infertility prevalence, delayed childbearing trends, and growing reliance on assisted reproductive technologies. Experts highlight that IVF laboratory automation, AI-based embryo selection, and advanced imaging systems will be key growth drivers. Continuous innovation in fertility preservation technologies and embryo culture systems is expected to significantly enhance treatment success rates and expand the market through 2035.